Wenhua Li, Jianling Zou, Jinjia Chang, Chenchen Wang, Mingzhu Huang, Zhiyu Chen, Xiaodong Zhu, Weijian Guo. "Second-line irinotecan followed by third-line cetuximab plus irinotecan versus second-line cetuximab combined with irinotecan in treatment of oxaliplatin/5-FU failure RAS/RAF wild-type mCRC patients: A randomized phase II study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.148